About DNAtrix
DNAtrix is a company based in Houston (United States) founded in 2005.. DNAtrix has raised $42.96 million across 11 funding rounds from investors including HHS, U.S. Food and Drug Administration and Mercury Fund. DNAtrix offers products and services including Slot Games and Betting Services. DNAtrix operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others.
- Headquarter Houston, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$42.96 M (USD)
in 11 rounds
-
Latest Funding Round
$852.57 K (USD), Grant
Sep 01, 2022
-
Investors
HHS
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DNAtrix
DNAtrix offers a comprehensive portfolio of products and services, including Slot Games and Betting Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for playing digital slot games with bonuses.
Services for placing bets on various games online.
Unlock access to complete
Unlock access to complete
Funding Insights of DNAtrix
DNAtrix has successfully raised a total of $42.96M across 11 strategic funding rounds. The most recent funding activity was a Grant round of $852.57 thousand completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Grant — $852,568
-
First Round
First Round
(19 Nov 2008)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2022 | Amount | Grant - DNAtrix | Valuation |
investors |
|
| Sep, 2018 | Amount | Series C - DNAtrix | Valuation |
investors |
|
| Aug, 2016 | Amount | Grant - DNAtrix | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in DNAtrix
DNAtrix has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, U.S. Food and Drug Administration and Mercury Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are directed toward US, India, and Canada firms.
|
Founded Year | Domain | Location | |
|
Early stage investments in medical and life science technologies are made by Targeted Technology.
|
Founded Year | Domain | Location | |
|
Multiple sectors are invested in by Morningside, a VC fund.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by DNAtrix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - DNAtrix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Dnatrix Comparisons
Competitors of DNAtrix
DNAtrix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Dnatrix
Frequently Asked Questions about DNAtrix
When was DNAtrix founded?
DNAtrix was founded in 2005 and raised its 1st funding round 3 years after it was founded.
Where is DNAtrix located?
DNAtrix is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Is DNAtrix a funded company?
DNAtrix is a funded company, having raised a total of $42.96M across 11 funding rounds to date. The company's 1st funding round was a Grant of $2M, raised on Nov 19, 2008.
What does DNAtrix do?
DNAtrix is a clinical stage company developing virus-driven immunotherapies for cancer. Its lead product, DNX-2401 is a conditionally replicative oncolytic virus being studied in clinical trials for recurrent glioblastoma (brain cancer) and is in Phase 3. Its pipeline includes viruses armed with potent immunomodulatory molecules that augment a patients immune system to trigger an aggressive anti-tumor T-cell response .
Who are the top competitors of DNAtrix?
DNAtrix's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does DNAtrix offer?
DNAtrix offers Slot Games and Betting Services.
Who are DNAtrix's investors?
DNAtrix has 5 investors. Key investors include HHS, U.S. Food and Drug Administration, Mercury Fund, Targeted Technology, and Morningside.